SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Innovative Medtech, Inc. – ‘10-K’ for 10/31/14 – ‘EX-32.1’

On:  Monday, 2/1/21, at 3:20pm ET   ·   For:  10/31/14   ·   Accession #:  1477932-21-572   ·   File #:  0-51390

Previous ‘10-K’:  ‘10-K’ on 2/1/21 for 10/31/13   ·   Next:  ‘10-K’ on 10/13/21 for 6/30/21   ·   Latest:  ‘10-K’ on 10/13/23 for 6/30/23   ·   18 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/01/21  Fresh Harvest Products, Inc.      10-K       10/31/14   47:2.4M                                   Discount Edgar/FA

Annual Report   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    384K 
 2: EX-31.1     Certifications                                      HTML     19K 
 3: EX-32.1     Certifications                                      HTML     15K 
10: R1          Cover                                               HTML     51K 
11: R2          Balance Sheets                                      HTML     58K 
12: R3          Balance Sheets (Parenthetical)                      HTML     29K 
13: R4          Statements of Operations                            HTML     56K 
14: R5          STATEMENT OF STOCKHOLDER'S' Equity                  HTML     25K 
15: R6          Statements of Cash Flows                            HTML     59K 
16: R7          General Organization and Business                   HTML     20K 
17: R8          Liquidity, Capital Resources and Going Concern      HTML     20K 
18: R9          Summary of Significant Accounting Policies          HTML     30K 
19: R10         Notes Payable - Related Parties                     HTML     16K 
20: R11         Notes Payable                                       HTML     68K 
21: R12         Derivative Liability                                HTML     37K 
22: R13         Stockholders Equity                                 HTML     21K 
23: R14         Provision for Corporate Income Taxes                HTML     22K 
24: R15         Unpaid Payroll Taxes                                HTML     16K 
25: R16         Commitments and Contingencies                       HTML     17K 
26: R17         Subsequent Events                                   HTML     20K 
27: R18         Summary of Significant Accounting Policies          HTML     54K 
                (Policies)                                                       
28: R19         Notes Payable (Tables)                              HTML     67K 
29: R20         Derivative Liability (Tables)                       HTML     39K 
30: R21         Provision for Corporate Income Taxes (Tables)       HTML     18K 
31: R22         General Organization and Business (Details          HTML     19K 
                Narrative)                                                       
32: R23         Liquidity, Capital Resources and Going Concern      HTML     25K 
                (Details Narrative)                                              
33: R24         Notes Payable - Related Parties (Details            HTML     23K 
                Narrative)                                                       
34: R25         Notes Payable (Details)                             HTML    135K 
35: R26         Derivative Liability (Details)                      HTML     17K 
36: R27         Derivative Liability (Details 1)                    HTML     20K 
37: R28         Derivative Liability (Details 2)                    HTML     27K 
38: R29         Derivative Liability (Details 3)                    HTML     21K 
39: R30         Stockholders Equity (Details Narrative)             HTML     22K 
40: R31         Provision for Corporate Income Taxes (Details)      HTML     25K 
41: R32         Provision for Corporate Income Taxes (Details       HTML     20K 
                Narrative)                                                       
42: R33         Unpaid Payroll Taxes (Details Narrative)            HTML     20K 
43: R34         Commitments and Contingencies (Details Narrative)   HTML     21K 
44: R35         Subsequent Events (Details Narrative)               HTML     70K 
46: XML         IDEA XML File -- Filing Summary                      XML     80K 
45: EXCEL       IDEA Workbook of Financial Reports                  XLSX     52K 
 4: EX-101.INS  XBRL Instance -- frhv-20141031                       XML    667K 
 7: EX-101.CAL  XBRL Calculations -- frhv-20141031_cal               XML     83K 
 9: EX-101.DEF  XBRL Definitions -- frhv-20141031_def                XML    157K 
 6: EX-101.LAB  XBRL Labels -- frhv-20141031_lab                     XML    437K 
 8: EX-101.PRE  XBRL Presentations -- frhv-20141031_pre              XML    336K 
 5: EX-101.SCH  XBRL Schema -- frhv-20141031                         XSD     90K 
47: ZIP         XBRL Zipped Folder -- 0001477932-21-000572-xbrl      Zip     63K 


‘EX-32.1’   —   Certifications


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  fhp_ex321.htm  
 C: 

EXHIBIT 32.1

 

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Fresh Harvest Products, Inc. (the “Registrant”) on Form 10-K for the year ended October 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael Jordan Friedman, Principal Executive Officer and the Principal Financial Officer of the Registrant, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

 

(1)

the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

 

 

 

(2)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

  

 

FRESH HARVEST PRODUCTS, INC.

 

 

 

 

Dated: February 1, 2021

By:

/s/ Michael Jordan Friedman

 

 

 

Michael Jordan Friedman

Chief Executive Officer, President,

Chief Financial Officer and Chairman

 

 

 

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/1/2110-K,  10-Q
For Period end:10/31/14
 List all Filings 


18 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/23/12  Innovative Medtech, Inc.          8-K:1,2,3,910/11/12    3:56M                                    Computerized Bo… Svcs/FA
12/29/11  Innovative Medtech, Inc.          8-K:1,3,9  11/15/11    2:1.9M                                   Computerized Bo… Svcs/FA
 5/25/11  Innovative Medtech, Inc.          10-K/A     10/31/10    5:10M                                    Computerized Bo… Svcs/FA
 5/10/11  Innovative Medtech, Inc.          8-K:1,3,9   5/04/11    2:944K                                   Computerized Bo… Svcs/FA
 3/09/11  Innovative Medtech, Inc.          8-K:1,3,5,9 3/02/11    2:7.3M                                   Computerized Bo… Svcs/FA
 4/30/10  Innovative Medtech, Inc.          8-K:1,2,3,9 3/02/10    3:10M                                    Computerized Bo… Svcs/FA
 6/24/09  Innovative Medtech, Inc.          8-K:1,2,3,8 6/18/09    6:631K                                   Computerized Bo… Svcs/FA
10/10/08  Innovative Medtech, Inc.          8-K:1,2,3,910/06/08    3:1.7M                                   Computerized Bo… Svcs/FA
 2/20/08  Innovative Medtech, Inc.          8-K:2,3,5,9 2/14/08    4:2.3M                                   Computerized Bo… Svcs/FA
 9/14/07  Innovative Medtech, Inc.          10QSB       7/31/07    5:2.4M                                   Computerized Bo… Svcs/FA
 6/14/07  Innovative Medtech, Inc.          10QSB       4/30/07    9:10M                                    Computerized Bo… Svcs/FA
 3/26/07  Innovative Medtech, Inc.          10QSB       1/31/07    6:4.6M                                   Computerized Bo… Svcs/FA
 3/01/07  Innovative Medtech, Inc.          8-K:2,3,9   2/26/07    3:1.3M                                   Computerized Bo… Svcs/FA
 2/09/07  Innovative Medtech, Inc.          10KSB      10/31/06    7:2.8M                                   Computerized Bo… Svcs/FA
 2/01/07  Innovative Medtech, Inc.          8-K:1,2,9   1/02/07    9:10M                                    Computerized Bo… Svcs/FA
 5/12/06  Innovative Medtech, Inc.          SB-2                  16:18M                                    Computerized Bo… Svcs/FA
 1/27/06  Innovative Medtech, Inc.          8-K:1,2,3,512/16/05    8:5.8M                                   Computerized Bo… Svcs/FA
 6/29/05  Innovative Medtech, Inc.          10SB12G                7:3.9M                                   Computerized Bo… Svcs/FA
Top
Filing Submission 0001477932-21-000572   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 3, 9:34:35.3am ET